Search

Home > The Bio Report > A New Class of Cancer Therapies Targets Solid Tumors with a Dual Action
Podcast: The Bio Report
Episode:

A New Class of Cancer Therapies Targets Solid Tumors with a Dual Action
Category: Business
Duration: 00:21:33
Publish Date: 2022-03-10 09:00:27
Description: Virus-like drug conjugates, or VDCs, are a new class of cancer therapies Aura Biosciences is developing to target a broad range of solid tumors. These therapies have a dual mechanism of action. They deliver a toxic payload to cancer cells, but also activate a secondary immune mediated response to kill cancer cells. We spoke to Elisabet de los Pinos, CEO of Aura Biosciences, about the company’s VDCs, how they work, and its pipeline in development.
Total Play: 0

Some more Podcasts by Levine Media Group

600+ Episodes
The Bio Repo ..